OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
May 03, 2024
Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent Pharmaceuticals private label.
The latest news for pharma industry insiders.
May 02, 2024
Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.
The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.
May 01, 2024
The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.
IATA data points to a fourth consecutive month of double-digit, year-on-year growth.
April 30, 2024
The merger exponentially grows ONO’s oncology pipeline.
The complex will research solutions for manufacturing antibodies, mRNA applications, and more.